Anebulo Pharmaceuticals Inc
For the period ended Apr 4, 2025. Filed Apr 7, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 4, 2025 · Filed Apr 7, 2025
Use the contents to explore the available documents and sections.
Contents
Proposal No. 1: Declassification Charter Amendment
The stockholders approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to provide for the declassification of the Company’s Board of Directors.
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|
| 28,314,986 | 1,924 | 18 | 278,561 |
Proposal No. 2: Election of Class I Directors.
The stockholders elected each of Joseph F. Lawler, Richard Anthony Cunningham, and Aron R. English to serve on the Board the terms of each, along with all other directors, will end at the annual meeting of stockholders of the Company that is held after the filing of the Declassification Charter Amendment (the “Initial Declassified Annual Meeting”), and commencing with the Initial Declassified Annual Meeting, all directors will stand for election at the Initial Declassified Annual Meeting for one-year terms.
| Nominee | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Joseph F. Lawler | 28,260,498 | 56,430 | 278,561 |
| Richard Anthony Cunningham | 28,273,918 | 43,010 | 278,561 |
| Aron R. English | 28,271,019 | 45,909 | 278,561 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.